TL
Publicaties op Oncologisch.com
Distant disease-free survival as a surrogate endpoint for totale overleving in randomised trials of neoadjuvant thera...
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer ...
Denosumab plus nab-paclitaxel neoadjuvant bij mammacarcinoom: GeparX fase II
GeparOcto: overlevingsanalyse van neoadjuvante chemotherapieschema's
Intensief dosisdicht versus aangepast dosisdicht adjuvant bij mammacarcinoom: fase III